Department of Intensive Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, and University of Twente, MIRA–Institute for Biomedical Technology and Technical Medicine, Enschede, The Netherlands
Department of Intensive Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Professor Pickkers served as a board member for Gamla Brogatans Sjukvårdsaffär Aktiebolag, Exponential Biotherapies Inc (EBI), and AM-Pharma; consulted for AM-Pharma and EBI; and lectured for Pfizer, Merck Sharp & Dhome, and Astellas. His institution received grant support from ZonMW, Nierstichting, and Reumafonds. The remaining authors have disclosed that they do not have any potential conflicts of interest.